Beijing, Beijing, China Related Funds
Funds with similar focus
| Fund Name | Location |
| 301 Ventures | College Park, Maryland, United States |
| 3M | Minnesota, Saint Paul, United States |
| Accretive LLC | New York, New York, United States |
| Apoteket AB | Solna, Stockholms Lan, Sweden |
| AZURE PLUS | Chiyoda, Japan |
| Chengdu High-tech Zone Venture Angel Fund | Chengdu, China, Sichuan |
| CNNSI.com | - |
| Colony Latam Partners | - |
| Daicheng Touzi | China, Shanghai |
| Deluxe Entertainment Services Group | Burbank, California, United States |
| Emerge Education | England, London, United Kingdom |
| Flywheel Ventures | New Mexico, Santa Fe, United States |
| Grey | New York, New York, United States |
| Highlander Venture Fund | - |
| Huilun Biological Technology | China, Shanghai |
| Liquid Value Capital | Beijing, Beijing, China |
| LSP | - |
| Maywood Street Investments | - |
| Sanan Private Equity | Clearwater, Florida, United States |
| Zhejiang Changxing Economic and Technological Development | China, Huzhou, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
NuProbe | $50M | 02 Jun 2022 | Boston, Massachusetts, United States | ||
Tianbing Technology | $15M | 08 Feb 2022 | Dongcheng District, Beijing, China | ||
Chemsemi | $154M | 21 Jan 2022 | Yangzhou, Jiangsu, China | ||
Changmugu Medical | $83M | 10 Nov 2021 | Dongcheng District, Beijing, China | ||
| $61M | 10 Mar 2021 | China, Guangdong Province, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
NuProbe | $50M | 02 Jun 2022 | Boston, Massachusetts, United States | ||
Tianbing Technology | $15M | 08 Feb 2022 | Dongcheng District, Beijing, China | ||
Chemsemi | $154M | 21 Jan 2022 | Yangzhou, Jiangsu, China | ||
Changmugu Medical | $83M | 10 Nov 2021 | Dongcheng District, Beijing, China | ||
| $61M | 10 Mar 2021 | China, Guangdong Province, China |
